{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:08:51Z","timestamp":1791198531150,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.nbd.2011.12.017","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T20:40:52Z","timestamp":1324672852000},"page":"983-991","source":"Crossref","is-referenced-by-count":44,"title":["Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Valentina","family":"Chiodi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motokazu","family":"Uchigashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Beggiato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Armida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Luisa","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Tanganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Domenici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Popoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.12.017_bb0005","doi-asserted-by":"crossref","first-page":"20564","DOI":"10.1073\/pnas.0706873104","article-title":"Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step","volume":"104","author":"Adermark","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.017_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-0270(01)00374-0","article-title":"The LTP program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events","volume":"15","author":"Anderson","year":"2001","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2011.12.017_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2007.04.012","article-title":"Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes","volume":"27","author":"Battista","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.017_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuint.2007.06.031","article-title":"Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6\/2 mice, a transgenic model of Huntington's disease","volume":"52","author":"Bisogno","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2011.12.017_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Bl\u00e1zquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.017_bb0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principles of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2011.12.017_bb0035","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/sj.npp.1300458","article-title":"A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission","volume":"29","author":"Centonze","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2011.12.017_bb0040","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.biopsych.2005.03.008","article-title":"Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6\/2 Huntington's disease mice","volume":"57","author":"Centonze","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.017_bb0045","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.017_bb0050","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.017_bb0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.12.017_bb0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","article-title":"Transcriptional dysregulation in Huntington's disease","volume":"23","author":"Cha","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2011.12.017_bb0065","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","article-title":"Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease","volume":"163","author":"Dowie","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.017_bb0070","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuroscience.2010.06.056","article-title":"Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice","volume":"170","author":"Dowie","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.017_bb0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/3-540-26573-2_16","article-title":"Cannabinoid control of motor function at the basal ganglia","volume":"168","author":"Fern\u00e1ndez-Ruiz","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.nbd.2011.12.017_bb0080","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00702-010-0389-4","article-title":"Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes. A novel action of cocaine","volume":"117","author":"Ferraro","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2011.12.017_bb0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0306-4522(92)90291-9","article-title":"Adenosine\u2013dopamine interactions in the brain","volume":"51","author":"Ferr\u00e9","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.017_bb0090","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1111\/j.0953-816X.2004.03384.x","article-title":"Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1\/M3-mediated indirect suppression through endocannabinoid signalling","volume":"19","author":"Fukudome","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.017_bb0095","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2011.12.017_bb0100","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington's disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.017_bb0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.017_bb0110","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington's disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2011.12.017_bb0115","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1523\/JNEUROSCI.4232-04.2005","article-title":"Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis","volume":"25","author":"Kofalvi","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.017_bb0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.12.017_bb0125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00001756-200305060-00007","article-title":"Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate","volume":"14","author":"Lastres-Becker","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2011.12.017_bb0130","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/00001756-200410250-00015","article-title":"Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo","volume":"15","author":"Lastres-Becker","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2011.12.017_bb0135","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0022-3565(24)37839-5","article-title":"Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes","volume":"287","author":"Lu","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2011.12.017_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pneurobio.2006.11.006","article-title":"The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases","volume":"81","author":"Maccarrone","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.12.017_bb0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.12.017_bb0230","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.12.017_bb0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1088208","article-title":"CB1 cannabinoid receptors and on-demand defense against excitotoxicity","volume":"302","author":"Marsicano","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.017_bb0155","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1471-4159.2010.07101.x","article-title":"Presynaptic adenosine A(2A) receptors control cannabinoid CB(1) receptor-mediated inhibition of striatal glutamatergic neurotransmission","volume":"116","author":"Martire","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.017_bb0160","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.nbd.2011.12.017_bb0165","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","article-title":"Worsening of Huntington disease phenotype in CB1 receptor knockout mice","volume":"42","author":"Mievis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.017_bb0170","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1046\/j.1460-9568.2003.02698.x","article-title":"Subtype switching of vesicular glutamate transporters at parallel fibre\u2013Purkinje cell synapses in developing mouse cerebellum","volume":"17","author":"Miyazaki","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.017_bb0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.12.017_bb0180","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.neuropharm.2006.06.013","article-title":"The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum","volume":"51","author":"Pintor","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2011.12.017_bb0185","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.017_bb0190","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/hmg\/2.6.637","article-title":"Improved PCR conditions for the stretch of (CAG)n repeats causing Huntington's disease","volume":"2","author":"Riess","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.12.017_bb0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2006.09.056","article-title":"Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease","volume":"410","author":"Rossi","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.12.017_bb0200","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1523\/JNEUROSCI.14-09-05325.1994","article-title":"Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation","volume":"14","author":"Schulz","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.017_bb0205","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1476-5381.2010.00735.x","article-title":"The endocannabinoid system as a target for the treatment of neurodegenerative disease","volume":"160","author":"Scotter","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2011.12.017_bb0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-2999(02)02148-9","article-title":"SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices","volume":"450","author":"Tebano","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2011.12.017_bb0215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.12.017_bb0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.017_bb0225","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1523\/JNEUROSCI.0448-07.2007","article-title":"Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum","volume":"27","author":"Uchigashima","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111003925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111003925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T14:15:16Z","timestamp":1742134516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111003925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0969996111003925"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.12.017","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}